Elysium Health

Elysium Health, established in 2014 by Leonard Guarente, Eric Marcotulli, and Dan Alminana, is a New York City-based company specializing in dietary supplements aimed at promoting health and longevity. Their inaugural product, Basis, introduced in 2015, combines nicotinamide riboside and pterostilbene—compounds associated with cellular health and aging processes.

Over the years, Elysium Health has expanded its product line to address various aspects of health:

• Index (2019): A test utilizing epigenetic analysis of saliva samples to estimate biological age.
• Matter (2020): A supplement developed to support brain health and potentially slow cognitive decline.
• Format (2021): Designed to support the immune system and promote healthy aging.
• Mosaic (2023): A daily supplement aimed at preventing skin aging and protecting collagen.
• Vision (2024): Formulated to maintain macular health and support long-term eye function.

The company has also been involved in legal disputes concerning patent infringements related to its products. Notably, in September 2021, a U.S. district judge dismissed claims by Dartmouth College and ChromaDex, invalidating their patents. This decision was upheld by the United States Court of Appeals for the Federal Circuit in February 2023.

Elysium Health continues to focus on developing science-backed supplements, collaborating with researchers to create products intended to enhance various aspects of health and longevity.

‍

‍